Cargando…

Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study

In this study, we compared the efficacy and tolerability of the combination of paracetamol 1,000 mg + caffeine 130 mg (PCF) with sumatriptan 50 mg (SUM) in migraine attacks. This was a multi-center randomized double-blind, double-dummy, cross-over controlled trial. The efficacy was assessed by the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pini, Luigi Alberto, Guerzoni, Simona, Cainazzo, Michela, Ciccarese, Michela, Prudenzano, Maria Pia, Livrea, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2012
Materias:	Clinical Trials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484257/ https://www.ncbi.nlm.nih.gov/pubmed/23054063 http://dx.doi.org/10.1007/s10194-012-0484-z

Ejemplares similares

Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium
por: Pini, Luigi Alberto, et al.
Publicado: (2008)

P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
por: Guerzoni, Simona, et al.
Publicado: (2015)

Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: a double-blind, double-dummy, randomised, parallel group, multicentre study
por: Sandrini, G, et al.
Publicado: (2007)

Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal
por: Baraldi, Carlo, et al.
Publicado: (2017)

Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study
por: Tfelt-Hansen, P., et al.
Publicado: (2006)

Influence of sumatriptan on the autonomic system during migraine attacks
por: Dalla Volta, G., et al.
Publicado: (2006)

Cilostazol induced migraine does not respond to sumatriptan in a double blind trial
por: Falkenberg, Katrine, et al.
Publicado: (2018)

Comparison between Intravenous Sodium Valproate and Subcutaneous Sumatriptan for Treatment of Acute Migraine Attacks; Double-Blind Randomized Clinical Trial
por: Rahimdel, Abolghasem, et al.
Publicado: (2014)

Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine
por: Cady, Roger K., et al.
Publicado: (2017)

Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey
por: Ferrari, Anna, et al.
Publicado: (2013)

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2017)

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2018)

Efficacy of the Jingxin Zhidong Formula for Tic Disorders: A Randomized, Double Blind, Double Dummy, Parallel Controlled Trial
por: Fan, Fei, et al.
Publicado: (2022)

Sumatriptan (50 and 100 mg) in repeated migraine attacks: a patient preference study
por: Zanchin, Georgio, et al.
Publicado: (2000)

Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
por: Goadsby, Peter J, et al.
Publicado: (2019)

Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
por: Guerzoni, Simona, et al.
Publicado: (2023)

Basal cutaneous pain threshold in headache patients
por: Zappaterra, Maurizio, et al.
Publicado: (2011)

Tenofovir disoproxil fumarate in Chinese chronic hepatitis B patients: Results of a multicenter, double-blind, double-dummy, clinical trial at 96 weeks
por: Chen, Xiao-Fan, et al.
Publicado: (2021)

New strategies for the treatment of migraine attacks
por: Genco, Sergio, et al.
Publicado: (2001)

Acute withdrawal and botulinum toxin A in chronic migraine with medication overuse: a double-blind randomized controlled trial
por: Pijpers, Judith A, et al.
Publicado: (2019)

Tramadol/paracetamol combination tablet for postoperative pain following ambulatory hand surgery: a double-blind, double-dummy, randomized, parallel-group trial
por: Rawal, Narinder, et al.
Publicado: (2011)

Efficacy of Sumatriptan/Placebo versus Sumatriptan/Propofol Combination in Acute Migraine; a Randomized Clinical Trial
por: Farahmand Rad, Reza, et al.
Publicado: (2022)

Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication–overuse headache
por: Pellesi, Lanfranco, et al.
Publicado: (2019)

Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache
por: Moore, Johanna C, et al.
Publicado: (2012)

Harnessing Intranasal Delivery Systems of Sumatriptan for the Treatment of Migraine
por: Assadpour, Sara, et al.
Publicado: (2022)

O015. Evaluation of the genetic polymorphism of the α3 (CHRNA3) and α5 (CHRNA5) nicotinic receptor subunits, in patients with cluster headache
por: Cainazzo, Maria Michela, et al.
Publicado: (2015)

Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study
por: Landy, Stephen, et al.
Publicado: (2018)

Results of a randomized, prospective, double-dummy, double-blind trial to compare efficacy and safety of a herbal combination containing Tropaeoli majoris herba and Armoraciae rusticanae radix with co-trimoxazole in patients with acute and uncomplicated cystitis
por: Stange, Rainer, et al.
Publicado: (2017)

Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trial
por: Tfelt-Hansen, Peer
Publicado: (2011)

A genome-wide analysis in cluster headache points to neprilysin and PACAP receptor gene variants
por: Bacchelli, Elena, et al.
Publicado: (2016)

A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)
por: Cady, Roger K, et al.
Publicado: (2015)

The Use of Neuroimaging for Predicting Sumatriptan Treatment Response in Patients With Migraine
por: Wu, Jr-Wei, et al.
Publicado: (2022)

Acupuncture as prophylaxis for chronic migraine: a protocol for a single-blinded, double-dummy randomised controlled trial
por: Liu, Lu, et al.
Publicado: (2018)

The comorbidity of migraine and hypertension. A study in a tertiary care headache centre
por: Prudenzano, M. P., et al.
Publicado: (2005)

Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial
por: Cao, Kegang, et al.
Publicado: (2016)

Pharmacokinetics study of chitosan-coated liposomes containing sumatriptan in the treatment of migraine
por: Assadpour, Sara, et al.
Publicado: (2022)

Proteomic research of proteins involved in pain expression in an animal model of chronic pain
por: Bellei, Elisa, et al.
Publicado: (2015)

Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial
por: Barbanti, Piero, et al.
Publicado: (2012)

Predictors of response to erenumab after 12 months of treatment
por: Baraldi, Carlo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3nj8kdnn8kppdf751kcqbg8opn